In the News

The Economic Times | 14.05.2024

In 3-5 years, Piramal Pharma can see 22- 25% EBITDA growth margins: Nandini Piramal

The Economic Times | 14.05.2024

In 3-5 years, Piramal Pharma can see 22- 25% EBITDA growth margins: Nandini Piramal

Mint | 14.05.2024

Piramal to focus on brownfield expansion, cut debt before acquisitions

The Hindu Business Line | 13.05.2024

On-patent and differentiated offerings will give Piramal Pharma an edge, says Chairperson

CNBC TV18 | 13.05.2024

Piramal Pharma aims to grow innovation business faster than generics

Business Standard | 13.05.2024

Piramal Pharma open to partnerships in OTC; eyes further debt reduction

Business Standard | 11.05.2024

Piramal Pharma Q4 profit Jumps 102% to Rs 101.3 cr, FY24 revenue Up 18%

CNBC TV18 | 10.05.2024

Piramal Pharma Q4 net profit zooms to ₹101 crore, decalres dividend

Deccan Herald | 01.03.2024

Piramal Pharma eyes 15% revenue uptick propelled by CDMO biz

CNBC TV18 | 23.02.2024

Piramal Pharma: The Road To Recovery

Livemint | 01.02.2024

Piramal Pharma Q3 FY24 results : profit at ₹10.11Cr, Revenue increased by 14.14% YoY

Business Today | 24.12.2023

MPW 2023: For Piramal Pharma Chairperson Nandini Piramal sustainability is synonymous with growth

Business Today | 11.12.2023

BT MPW 2023: Nandini Piramal says not all companies maintain high standards in Indian pharma

Business Today | 09.12.2023

Infosys founders are an inspiration': Ajay Piramal's daughter and Piramal Pharma chief looks at Nandan Nilekani as an idol

Business Today | 08.12.2023

#BTMPW 2023: A Path Of Leadership And Innovative Brilliance

Business Today | 04.12.2023

Piramal Pharma allocates Rs 330 crore towards capex H2FY24

Pharma Boardroom | 30.11.2023

Peter DeYoung – CEO, Global Pharma, Piramal Pharma Limited

Times of India | 18.11.2023

Piramal Pharma focuses on organic growth, cost check

The Financial Express | 08.11.2023

We will focus on revenue growth, cost optimisation, and debt reduction: Nandini Piramal, Chairperson, Piramal Pharma

Business Standard | 07.11.2023

Should touch Rs 1K crore from OTC this year, says Nandini Piramal

The Hindu BusinessLine | 06.11.2023

Recovery and turnaround this year - Piramal Pharma Chairperson

Mint | 28.10.2023

Piramal Pharma revenue up 11% to ₹1,911 crore in Q2

CNBC-TV18 | 28.09.2023

Piramal Pharma's US manufacturing unit successfully completes USFDA inspection

Money Control | 27.09.2023

Piramal Pharma up almost 4% on green signal from US FDA for Bethlehem plant

Pharm Tech | 13.09.2023

Interview with Piramal’s Peter DeYoung at DCAT

Business Standard | 08.09.2023

Piramal Pharma is aiming to achieve zero waste to landfill by FY25

BW Legal World | 06.09.2023

Sebi Disposes Of Proceeding Against Piramal Pharma

The Economic Times | 30.08.2023

REC, Zee and NCC among stocks with up to 25% upside

Capital Market | 22.08.2023

Piramal Pharma allots 12.96 cr equity shares on rights basis

Adgully | 11.08.2023

Piramal Consumer Products Division introduces i-activ menstrual cups in their active range

Mint | 08.08.2023

Piramal Pharma rights issue opens today. Price, ratio, other details in five points

The Economic Times | 04.08.2023

Piramal Pharma posts net loss of Rs 99 crore in Q1FY24

CNBC TV18 | 02.08.2023

Piramal Pharma Rights Issue: Record date today, here's all you need to know

The Economic Times | 01.08.2023

Pickup in contract manufacturing biz set to drive growth: Piramal Pharma

Moneycontrol | 28.07.2023

Piramal Pharma rights issue at Rs 81 a share, opens August 8

The Economic Times | 18.07.2023

Piramal Pharma's Rs 1,050-cr rights issue gets Sebi's nod

Passionate Marketing | 28.06.2023

Piramal Consumer Products division expands the Tetmosol soap brand; introduces the Icy Cool variant

Business Standard | 06.06.2023

Piramal Critical Care appoints US-based Jeffrey Hampton as President, COO

The Economic Times | 26.05.2023

Piramal Pharma may double in a year; 4 metal stocks can give 20% return in 3 months : Sanjiv Bhasin

Mint | 25.05.2023

Earnings Impact: Piramal Pharma soars 13% as company turns profitable in March quarter

Pharmtech | 09.05.2023

Plus Therapeutics Expands Collaboration with Piramal Pharma Solutions

The Economic Times | 09.05.2023

IPL-flavoured portfolio: Smallcase manager Divam Sharma reveals his playing XI stocks

CNBC-TV18 | 18.04.2023

US FDA completes inspection at Piramal Pharma Sellersville manufacturing unit

The Economic Times | 11.04.2023

Hyderabad emerging as life sciences hub, with global and domestic pharmaceutical firms

The Hindu Business Line | 06.04.2023

Piramal Pharma Rights issue: Negatives priced in

Moneycontrol | 03.04.2023

Piramal Pharma zooms 5% on zero observations from US FDA

Free Press Journal | 01.04.2023

US FDA conducts GMP inspection at Piramal Pharma's Digwal facility

Business Today | 06.03.2023

MPW 2022: How Nandini Piramal is growing Piramal Pharma

The Hindu Business Line | 24.02.2023

Access to capital, regulatory reforms key to boost innovation in pharma industry: CEOs

ET Healthworld | 26.02.2023

Top Pharma CEOs optimistic about future growth opportunities, foresee the rise of India on global stage

Outsourcing Pharma | 21.02.2023

Piramal begins production at API facility in Michigan

Business Standard | 16.02.2023

Piramal Pharma gains after US facility gets EIR

The Economic Times | 09.02.2023

Piramal Pharma Q3 Results: Firm reports Rs 90 cr loss, gets board nod to raise up to Rs 1,050 cr

Medical Buyer | 09.02.2023

Piramal pharma shared down 10% on weak operational performance

Business Today | 17.01.2023

Piramal Pharma is emerging as a new pharma giant; what's driving the company's growth?

CNBC-TV18 | 14.01.2023

USFDA issues Form-483 with two observations to Piramal Pharma's Sellersville unit

The Economic Times | 11.01.2023

Carlyle buys wellness & beauty co VLCC, pays $275-$300 mn for nearly 70% stake

The Hindu Business Line | 09.01.2023

Pharma’s deal street. Managing bottomlines without losing sight of patient needs

The Economic Times | 19.12.2022

Piramal Pharma expects healthy growth in its key businesses. But does it cure the debt ailment?

Business Standard | 09.11.2022

Piramal Pharma posts Q2 net loss of Rs 37 cr, revenue grows to Rs 1,720 cr

Business Standard | 27.10.2022

MSCI sets aside Piramal Pharma's exclusion from global standard index

Indiainfoline | 25.10.2022

Piramal Pharma to invest Rs1,200 in UK over the next 12 to 18 months

The Economic Times | 25.10.2022

Piramal Pharma to inject funds into expansion, acquisitions

India Education Diary | 20.10.2022

Piramal Pharma Introduces Nixit, Its Smoking Cessation Brand With A New Campaign #QuititwithNixit In Karnataka

The Indian Express | 20.10.2022

Piramal Pharma falls 4.98 pc after listing

Financial Express | 20.10.2022

Piramal Pharma earmarks Rs 1,200 cr capex over next 24 months: Nandini

Mint | 20.10.2022

‘Our plan will allow us to grow 15% annually over 3-5 years’

The Economic Times | 20.10.2022

Piramal Pharma gets locked in lower circuit

CNBC TV18 | 20.10.2022

Indian pharma industry is ‘recession proof’: Piramal Chairman

India Education Diary | 20.10.2022

Piramal Pharma Introduces Nixit, Its Smoking Cessation Brand With A New Campaign #QuititwithNixit In Karnataka

Mint | 19.10.2022

Piramal Pharma shares list on stock exchanges after demerger

Business Standard | 19.10.2022

We won't make an acquisition just because we have to: Piramal Pharma chief

The Economic Times | 19.10.2022

Piramal Pharma shares hit 5% lower circuit after listing

Business Standard | 19.10.2022

Piramal Pharma ends at Rs 192 on debut, valued at Rs 22,882 cr at close

India Today | 19.10.2022

Yapan Bio Adds New Process Development Facility; Expands Capacity and Capabilities in Large Molecule Therapeutics

Moneycontrol | 17.10.2022

Piramal Pharma to list shares on October 19

The Economic Times | 17.10.2022

Piramal Pharma to debut on bourses on Wednesday

ET Healthworld | 10.10.2022

Piramal Pharma unveils its Sustainability Report FY21–22

Market Screener | 29.09.2022

Piramal Enterprises : Pharma Appoints Vibha Paul Rishi as Non- Executive Director to its Board of Directors

BW Disrupt | 22.09.2022

Piramal Pharma's Consumer Division Introduces D2C Platform Wellify

The Economic Times | 13.09.2022

Piramal Pharma in Talks for $225m Offshore Loans

LinkedIn Feeds